P
PurePeptides
Peptide Vendor. Lab-tested. Independently scored.
0.0
0 reviews · Poor
- 14 HPLC samples across 3 products
- Catalog avg purity 61.0%
- Independent testing, no pay-to-rank
Boren Health independently tests products and verifies reviews. Public methodology, no pay-to-rank.
Lab testing results
Independent results across 3 products.
14
Total lab tests
61.0%
Avg purity
94.0%
Best score
35.0%
Worst score
Tested products
| Product | Grade | Tests | Avg | Range | Latest | Price | $/mg |
|---|---|---|---|---|---|---|---|
| Retatrutide | AGREAT | 4 | 77.0% | 68.0% – 94.0% | 3/20/2025 | — | — |
| Tirzepatide | BGOOD | 6 | 70.0% | 66.0% – 78.0% | 9/4/2025 | — | — |
| Ipamorelin | EBAD | 4 | 36.0% | 35.0% – 37.0% | 3/20/2025 | — | — |
Individual lab tests
Tirzepatide7.3
Date
9/4/2025
Purity
99.79%
Quantity
30mg → 28.100mg
Lab
Lab E
Tirzepatide6.6
Date
8/11/2025
Purity
99.9%
Quantity
60mg → 65.700mg
Lab
Lab E
Ipamorelin3.7
Date
3/20/2025
Purity
79.31%
Quantity
2mg → 1.440mg
Lab
Lab B
Tirzepatide7.8
Date
3/20/2025
Purity
99.98%
Quantity
10mg → 11.400mg
Lab
Lab B
Retatrutide7.2
Date
3/20/2025
Purity
99.93%
Quantity
10mg → 11.860mg
Lab
Lab B
Ipamorelin3.6
Date
3/5/2025
Purity
79.97%
Quantity
2mg → 1.228mg
Lab
Lab C
Ipamorelin3.6
Date
3/5/2025
Purity
79.84%
Quantity
2mg → 1.183mg
Lab
Lab C
| Product | Date | Score | Purity | Quantity | Lab |
|---|---|---|---|---|---|
| Tirzepatide | 9/4/2025 | 7.3 | 99.79% | 30mg → 28.100mg | Lab E |
| Tirzepatide | 8/11/2025 | 6.6 | 99.9% | 60mg → 65.700mg | Lab E |
| Ipamorelin | 3/20/2025 | 3.7 | 79.31% | 2mg → 1.440mg | Lab B |
| Tirzepatide | 3/20/2025 | 7.8 | 99.98% | 10mg → 11.400mg | Lab B |
| Retatrutide | 3/20/2025 | 7.2 | 99.93% | 10mg → 11.860mg | Lab B |
| Ipamorelin | 3/5/2025 | 3.6 | 79.97% | 2mg → 1.228mg | Lab C |
| Ipamorelin | 3/5/2025 | 3.6 | 79.84% | 2mg → 1.183mg | Lab C |
Review summary
Synthesized from reviews · AI
No reviews have been submitted yet for PurePeptides.
About PurePeptides
Peptide VendorContact
All reviews
0.0
0 total
No reviews found matching your criteria.